돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2219069생성일: 2026년 10월 27일

2-(2-Furanyl)-7-(2-phenylethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine → Adenosine

https://huagongshe.com/reaction/2219069

반응식

참여 물질

역할이름HCID투입량
반응물2-(2-Furanyl)-7-(2-phenylethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amineHCID 176408—
반응물NecaHCID 448222—
반응물[3H]DpcpxHCID 53319341—
생성물AdenosineHCID 60961—

반응 단계

Perform assays in deep well 96 well plates. Total assay volume is 200 μl. Add 50 μl compound dilution buffer (total ligand binding) or 50 μl CGS 15923 working solution (A2a non-specific binding) or 50 μl NECA working solution (A1 non-specific binding) or 50 μl of drug working solution. Add 50 μl ligand stock ([3H]-SCH 58261 for A2a, [3H]-DPCPX for A1). Add 100 μl of diluted membranes containing the appropriate receptor. Mix. Incubate at room temperature for 90 minutes. Harvest using a Brandel cell harvester onto Packard GF/B filter plates. Add 45 μl Microscint 20 (Packard), and count using the Packard TopCount Microscintillation Counter. Determine IC50 values by fitting the displacement curves using an iterative curve fitting program (Excel). Determine Ki values using the Cheng-Prusoff equation.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07414058B2
출처 데이터셋uspto-grants-2008_08
ORD IDord-f5a84f56fd9649cc8aeb39eb4fb00ebd
출처 메모uspto-grants-2008_08